Chronic Lymphocytic Leukaemia
![Pirtobrutinib Shows Promise as a Novel CLL_SLL Treatment for Patients Previously Treated with BTK Inhibitors - Lates USA Pharma News By Pharmtales](https://pharmtales.com/wp-content/uploads/2023/07/Pirtobrutinib-Shows-Promise-as-a-Novel-CLL_SLL-Treatment-for-Patients-Previously-Treated-with-BTK-Inhibitors.jpg)
Pirtobrutinib Shows Promise as a Novel CLL/SLL Treatment for Patients Previously Treated with BTK Inhibitors
SG Tylor
Source – Eli Lilly On July 6, 2023, Eli Lilly and Company’s oncology unit announced that The New England Journal ...